| |
With three foreign trade zones, including the largest non-contiguous zone in the U.S., bioscience firms in Puerto Rico profit from affordable international trade. It's not what's next, it's where. Puerto Rico.
|
|
Today’s Big NewsMay 10, 2024 |
|
Tuesday, May 14, 2024 | 9:30am ET / 6:30am PT This webinar dives into patient-derived organoids viewed as the gold standard in bridging the gap between the lab and the clinic. The oncology portfolio allows researchers to incorporate patient relevance at every stage of the drug development pipeline - from target discovery and hit identification to lead validation and optimization. Register now.
|
|
| By Nick Paul Taylor MacroGenics’ safety woes have followed into phase 2. Having dialed down the dose in response to early-phase data, the biotech's stock cratered after reporting five deaths alongside an over 50% rate of grade 3 or worse adverse events. |
|
|
|
By Kevin Dunleavy After years of missteps in developing and commercializing its coronavirus shot, Novavax is turning to one of the biopharma industry’s most experienced vaccine companies to help salvage its COVID efforts. Sanofi will partner with the struggling Maryland biotech to co-commercialize its COVID-19 jab Nuvaxovid and develop combination vaccines. |
By Conor Hale About 100 days after implanting its first human participant with its brain-computer interface chip, Neuralink reported that some of the hair-thin connecting wires laced into the tissue have stopped reporting back data. |
By Andrea Park Roche’s long-awaited challenge to Regeneron’s dominance in the ophthalmology market may soon be coming to a head, according to a recent analyst report from GlobalData. |
|
Tuesday, May 16, 2024 | 10 ET / 7am PT Clinical trials are shifting towards sustainability and efficiency, necessitating industry leaders to embrace innovative provisioned device solutions. This webinar reveals new approaches reshaping the clinical trial supply chain to mitigate carbon footprints and revolutionize device lifecycle management. Explore how proactive sustainability in device management can differentiate leading companies in life sciences innovation.
|
|
By Max Bayer,Gabrielle Masson Sanofi's CSO has left the company amid a global R&D restructuring. Pfizer tags longtime Citi analyst for C-suite-level strategy role. Acelyrin's found CEO shocking leaves. |
By Angus Liu Right after an industry survey suggested that switching away from Chinese CDMOs could take biopharma companies up to eight years, lawmakers have adjusted the BIOSECURE Act. The new draft lays out a 2032 deadline for the separation mandate and adds WuXi Biologics to the list of targets. |
By Nick Paul Taylor Salix Pharmaceuticals is stepping up its promotion of Xifaxan in overt hepatic encephalopathy, putting award-winning actor Bellamy Young at the heart of a campaign to raise awareness of the liver disease complication. |
By Fraiser Kansteiner AGC Biologics, which employs more than 2,500 workers worldwide, has “had to reduce positions at our Seattle and Colorado sites and global functional areas,” a spokesperson confirmed Friday in an emailed statement. The percentage of planned cuts suggests AGC could ultimately lay off around 100 employees. |
By Annalee Armstrong Linda Burkly, Ph.D., was 37 years into a career at Biogen when Editas CEO Gilmore O’Neill—himself an alum of the neurological disease-focused big biotech—came knocking. |
By Conor Hale The Ethicon branch recalled its Mega Soft and Mega 2000 return electrodes in June 2023 after reports of injuries including third-degree burns. |
By Andrea Park Through the campaign, Midol and Period. plan to open up candid conversations about periods and the menstrual cycle as a whole, while also providing information about the medications and other resources available to help treat period symptoms. |
By Max Bayer The FDA needs a few more weeks to decide the fate of Moderna's RSV vaccine, the company announced. A decision is now slated for the end of May, as opposed to May 12. |
Fierce podcastsDon’t miss an episode |
| | This week’s episode of “The Top Line,” kicks off a series diving into the latest advancements in cell and gene therapy manufacturing. |
|
|---|
|
|
|
Wednesday, May 22, 2024 | 11am ET / 8 am PT Learn GMP regulations in pharmaceutical storage at our upcoming webinar. Discover FDA requirements, including space validation, environmental controls, and risk mitigation. Explore services like aliquoting and cold chain transportation. Register now.
|
|
| WhitepaperPrecision collection of cell therapy source material doesn’t happen by chance. Our new whitepaper illuminates the science and strategies for successful apheresis. Sponsored by: Comprehensive Cell Solutions |
| WhitepaperLearn how Specifica’s in vitro antibody discovery platform can deliver better antibodies than traditional immunization approaches. Sponsored by: Specifica, a Q2 Solutions company |
| WhitepaperThis paper defines “digital companions” in biopharma, explores their value from the patient & company perspectives, & outlines a process for successfully fielding a new digital companion. Presented by: Blue Matter, strategic consultants in the life sciences |
| WhitepaperExplore the complex considerations of vaccine development for influenza and COVID-19, including the challenges posed by viral evolution and the importance of ongoing research in this paper by vaccine expert, Dr. Lisa Kierstead. Sponsored by: PPD®️ Laboratory Services |
| eBookTo make every rare disease trial count, we design patient-centric, relevant strategies for sponsors and caregivers to produce impactful results every time. Sponsored by: Emmes Company |
| WhitepaperDiscover the secrets behind successful patient engagement Sponsored by: ProofPilot |
| WhitepaperAntibody biomarkers are redefining precision medicine, from diagnosing diseases earlier to stratifying patients – download your FREE white paper today! Sponsored by: Sengenics Corporation LLC |
| WhitepaperThe use of prefilled syringes to administer biotherapeutics is beginning to gain traction because they offer a range of stability, efficacy, and patient safety benefits. Download this white paper to learn how Lonza has developed a novel workflow to ensure confidence regarding functionality in PFS and autoinjectors. Presented by Lonza |
On Helix Date: 4 July 2024 - Location: Babraham Research Campus, Cambridge UK |
|
| |
|
